The impact of Renin-Angiotensin System Inhibitors on bone fracture risk: a nationwide nested case-control study
Abstract Background The therapeutic efficacy of renin-angiotensin system inhibitors (RASi) in elderly patients with hypertension and at risk of fractures has been in the limelight because of accumulating evidence that localized RAS activation in bone tissue leads to osteoclastic bone resorption, res...
Main Authors: | Kwang Min Kim, Eun Jung Hwang, Sangjin Lee, Jeong-Hyun Yoon |
---|---|
Format: | Article |
Language: | English |
Published: |
BMC
2024-01-01
|
Series: | BMC Musculoskeletal Disorders |
Subjects: | |
Online Access: | https://doi.org/10.1186/s12891-023-07102-5 |
Similar Items
-
Medicinal chemistry of the renin-angiotensin system /
by: Timmermans, P. B. M. W. M., et al.
Published: (1994) -
Renin-angiotensin system inhibitors improve the clinical outcomes of COVID-19 patients with hypertension
by: Juan Meng, et al.
Published: (2020-01-01) -
Correlation with renin-angiotensin-aldosterone and glomerular filtration rate in chronic renal failure patients
by: Fatimah Kadhim Ibrahim AL-Mahdawi ,, et al.
Published: (2023-06-01) -
RENIN-ANGIOTENSIN SYSTEM IN REGULATION OF HEMATOPOIESIS
by: M. L. Kanaeva, et al.
Published: (2018-02-01) -
The Role of Renin–Angiotensin System in Diabetic Cardiomyopathy: A Narrative Review
by: João Pedro Thimotheo Batista, et al.
Published: (2023-07-01)